Evidence map›Paper›PMID 21821379›Full record

ArticleJournal of substance abuse treatment2011

A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.

Traci R Rieckmann, Anne E Kovas, Bentson H McFarland, Amanda J Abraham

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  6. Article
  7. Article
  8. Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Traci R RieckmannDepartment of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR 97239, USA. rieckman@ohsu.edu
Anne E Kovas
Bentson H McFarland
Amanda J Abraham
Oregon Health & Science University · USUniversity of Georgia · US

Funding

ADOPTION OF INNOVATIONS IN PRIVATE A&D TREATMENT CENTERSR01DA013110 · NIDA · UNIVERSITY OF GEORGIA (UGA) · PI ROMAN, PAUL M · 1999 to 2010
$4.9M
Adoption of Evidence-Based Practices in Substance Abuse TreatmentK23DA021225 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI RIECKMANN, TRACI R · 2008 to 2011
$619k
NIDA NIH HHS 5K23DA021225NIDA NIH HHS K23 DA021225NIDA NIH HHS R01 DA013110NIDA NIH HHS R01DA13110
6 · The paper itself

Abstract

Despite evidence that buprenorphine is effective and safe and offers greater access as compared with methadone, implementation for treatment of opiate dependence continues to be weak. Research indicates that legal and regulatory factors, state policies, and organizational and provider variables affect adoption of buprenorphine. This study uses hierarchical linear modeling to examine National Treatment Center Study data to identify counselor characteristics (attitudes, training, and beliefs) and organizational factors (accreditation, caseload, access to buprenorphine, and other evidence-based practices) that influence implementation of buprenorphine for treatment of opiate dependence. Analyses showed that provider training about buprenorphine, higher prevalence of opiate-dependent clients, and less treatment program emphasis on a 12-step model predicted greater counselor acceptance and perceived effectiveness of buprenorphine. Results also indicate that program use of buprenorphine for any treatment purpose (detoxification, maintenance, and/or pain management) and time (calendar year in data collection) was associated with increased diffusion of knowledge about buprenorphine among counselors and with more favorable counselor attitudes toward buprenorphine.

Indexed as

Attitude of Health PersonnelAnalgesics, OpioidAttitudeBuprenorphineCounselingCultureFemaleHumansMaleMethadoneMiddle AgedNarcotic AntagonistsOpioid-Related DisordersSubstance-Related DisordersSurveys and QuestionnairesAnalgesics, OpioidBuprenorphineMethadoneNarcotic Antagonists

Identifiers

PMID21821379
PMCPMC3486698
OpenAlexW2119653958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.